Progress in Neuro-Psychopharmacology and Biological Psychiatry | 2021

Hair endocannabinoid concentrations in individuals with acute and weight-recovered anorexia nervosa

 
 
 
 
 
 
 
 
 

Abstract


BACKGROUND\nThe endocannabinoid system has been suggested to modulate energy metabolism and stress response and could be an important factor in the pathophysiology of anorexia nervosa (AN). In the context of AN, excessive physical activity may influence endocannabinoid concentrations. The objective of this study was to investigate hair endocannabinoid concentrations at different stages of the disorder. Measurement in hair allows for a cumulative assessment of endocannabinoid concentrations independent of circadian rhythms.\n\n\nMETHODS\nIn a combined cross-sectional and longitudinal design, we measured hair concentrations of the endocannabinoids anandamide and 2-arachidonoylglycerol and the endocannabinoid-related compounds palmitoylethanolamide, oleoylethanolamide, and stearoylethanolamide in female underweight patients with acute AN (n\u202f=\u202f67, reassessment of n\u202f=\u202f47 after short-term weight restoration with a body mass index increase of at least 14%), individuals long-term recovered from AN (n\u202f=\u202f27), and healthy control participants (n\u202f=\u202f84).\n\n\nRESULTS\nHair concentrations of anandamide and all endocannabinoid-related compounds were elevated in acute AN and decreased over the course of short-term weight restoration. Anandamide concentrations remained elevated in long-term recovered AN patients. In long-term recovered patients, physical activity correlated positively with the concentrations of all endocannabinoid-related compounds.\n\n\nCONCLUSION\nThe current study provides evidence for a significant alteration of the endocannabinoid system in acute AN, which may partly persist into long-term recovery. The endocannabinoid system may be a possible target for pharmaceutical interventions in AN, which should be explored in further preclinical and subsequently clinical randomized controlled trials.

Volume 107
Pages None
DOI 10.1016/j.pnpbp.2021.110243
Language English
Journal Progress in Neuro-Psychopharmacology and Biological Psychiatry

Full Text